DIA428.04+1.49 0.35%
SPX5,963.60+5.22 0.09%
IXIC19,215.46+4.36 0.02%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·12/11/2024 21:06:10
Listen to the news

Gainers

  • Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 172.2% to $12.55 during Wednesday's pre-market session. The company's market cap stands at $407.5 million.
  • NewGenIvf Group (NASDAQ:NIVF) stock rose 34.75% to $0.53. The company's market cap stands at $5.3 million.
  • Patterson Cos (NASDAQ:PDCO) stock moved upwards by 34.18% to $31.01. The market value of their outstanding shares is at $2.7 billion. As per the news, the Q2 earnings report came out 4 days ago.
  • Synlogic (NASDAQ:SYBX) stock increased by 17.3% to $1.7. The market value of their outstanding shares is at $19.8 million.
  • Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 14.86% to $0.85. The company's market cap stands at $3.6 million.
  • Moleculin Biotech (NASDAQ:MBRX) shares moved upwards by 14.71% to $2.65. The market value of their outstanding shares is at $7.9 million.

Losers

  • Q32 Bio (NASDAQ:QTTB) shares declined by 67.0% to $8.05 during Wednesday's pre-market session. The market value of their outstanding shares is at $98.0 million.
  • Cellectar Biosciences (NASDAQ:CLRB) shares decreased by 66.41% to $0.43. The company's market cap stands at $17.7 million.
  • AnaptysBio (NASDAQ:ANAB) shares declined by 36.51% to $14.66. The market value of their outstanding shares is at $446.0 million.
  • TFF Pharmaceuticals (NASDAQ:TFFP) shares declined by 33.88% to $0.2.
  • ImmunityBio (NASDAQ:IBRX) stock declined by 28.24% to $3.33. The market value of their outstanding shares is at $2.3 billion.
  • Hepion Pharmaceuticals (NASDAQ:HEPA) stock fell 26.93% to $0.46. The market value of their outstanding shares is at $3.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.